4-HO-PiPT
Chemical compound
Identifiers | |
---|---|
| |
Chemical and physical data | |
Formula | C16H24N2O |
Molar mass | 260.381 g·mol−1 |
3D model (JSmol) |
|
| |
InChI
|
4-Hydroxy-N-propyl-N-isopropyltryptamine (4-HO-PiPT, Piprocin) is a substituted tryptamine derivative which is claimed to have psychedelic effects. It acts as a 5-HT2A receptor agonist, with an EC50 of 13.8 nM and an efficacy of 104.8% (vs 5-HT),[1] and has been sold as a designer drug, first being identified in 2021 in British Columbia, Canada.[2]
See also
- 4-HO-DPT
- 4-HO-DiPT
- 4-HO-DSBT
- 4-HO-EiBT
- 4-HO-McPT
- 4-HO-McPeT
- 5-MeO-PiPT
- Ebalzotan
- Propylisopropyltryptamine
References
- ^ Banister S, Jorgensen W, Jinlong T. Compounds. Patent WO 2023/115167
- ^ Knill A, Tobias S, Matthews J, Ti L (June 2022). A Report on British Columbia's Unregulated Drug Supply. Drug checking trends across British Columbia, January to December 2021 (PDF). British Columbia Centre on Substance Use (Report).
- v
- t
- e
- 1-Methylpsilocin
- 2,alpha-DMT
- 2-Me-DET
- 2-Methyl-5-HT
- 2,N,N-TMT
- 4,5-DHP-DMT
- 4,5-MDO-DMT
- 4,5-MDO-DiPT
- 4-AcO-DALT
- 4-AcO-DET
- 4-AcO-DMT
- 4-AcO-DiPT
- 4-AcO-EPT
- 4-AcO-NMT
- 4-AcO-MALT
- 4-AcO-MET
- 4-AcO-DPT
- 4-AcO-MiPT
- 4-F-5-MeO-DMT
- 4-HO-5-MeO-DMT
- 4-HO-DALT
- 4-HO-DBT
- 4-HO-DET
- 4-HO-DiPT
- 4-HO-DPT
- 4-HO-DSBT
- 4-HO-EPT
- 4-HO-MALT
- 4-HO-MET
- 4-HO-McPT
- 4-HO-McPeT
- 4-HO-MiPT
- 4-HO-MPMI
- 4-HO-MPT
- 4-HO-MsBT
- 4-HO-NMT
- 4-HO-PiPT
- 4-HO-pyr-T
- 4-HO-αMT
- 4-Me-αET
- 4-Me-αMT
- 4-MeO-DiPT
- 4-MeO-DMT
- 4-MeO-MiPT
- 4-PrO-DMT
- 5,6-MeO-MiPT
- 5,6-MDO-DiPT
- 5,6-MDO-DMT
- 5,6-MDO-MiPT
- 5,7-Dihydroxytryptamine
- 5-BT
- 5-Bromo-DMT
- 5-CT
- 5-Chloro-αMT
- 5-Chloro-DMT
- 5-Ethoxy-αMT
- 5-Ethoxy-DMT
- 5-Ethyl-DMT
- 5-Fluoro-AET
- 5-Fluoro-αMT
- 5-Fluoro-DET
- 5-Fluoro-DMT
- 5-Fluoro-EPT
- 5-Fluoro-MET
- 5-HO-αMT
- 5-HO-DiPT
- 5-HTP
- 5-iPrO-AMT
- 5-MeS-DMT
- 5-Methoxytryptamine
- 5-MeO-7,N,N-TMT
- 5-Methyl-αET
- 5-MeO-2-TMT
- 5-MeO-αET
- 5-MeO-αMT
- 5-MeO-DALT
- 5-MeO-DBT
- 5-MeO-DET
- 5-MeO-DiPT
- 5-MeO-DMT
- 5-MeO-DPT
- 5-MeO-EiPT
- 5-MeO-EPT
- 5-MeO-MALT
- 5-MeO-MET
- 5-MeO-MiPT
- 5-MeO-MPMI
- 5-MeO-NMT
- 5-MeO-pyr-T
- 5-MeO-NBpBrT
- 5-Methyl-DMT
- 5-(Nonyloxy)tryptamine
- 6-Fluoro-αMT
- 6-Fluoro-DMT
- 6-Hydroxymelatonin
- 6-MeO-THH
- 7-Chloro-AMT
- 7-Methyl-α-ethyltryptamine
- 7-Methyl-DMT
- Acetryptine
- Aeruginascin
- αET
- Alpha,N-DMT
- α,N,N-Trimethyltryptamine
- Alpha,N,O-TMS
- AL-37350A
- αMT
- Baeocystin
- BNC-210
- Bufotenidine
- Bufotenin (5-HO-DMT)
- BW-723C86
- Convolutindole A
- CP-132,484
- DALT
- DBT
- Desformylflustrabromine
- DET
- DiPT
- DPT
- E-6801
- E-6837
- Ethocybin
- EiPT
- EMDT
- EPT
- FGIN-127
- FGIN-143
- Harmaline
- HIOC
- Ibogaine
- Idalopirdine
- Indorenate
- Iprocin
- Lespedamine
- Luzindole
- MET
- Methylbutyltryptamine
- MiPT
- MPT
- Miprocin
- Melatonin
- MPMI
- MS-245
- NAS
- N-Ethyltryptamine
- N-Feruloylserotonin
- NMT
- DMT
- Norbaeocystin
- Normelatonin
- N-t-Butyltryptamine
- O-4310
- Oxypertine
- Plakohypaphorine
- PiPT
- Psilocin (4-HO-DMT)
- Psilocybin (4-PO-DMT)
- Pyr-T
- Rizatriptan
- RU-28306
- Serotonin
- ST-1936
- Sumatriptan
- Tryptamine
- Tryptophan
- Yohimbine
- Yuremamine
- Zolmitriptan
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e